Navigation Links
Renhuang Pharmaceuticals, Inc. Announces Solid Fourth Quarter and Fiscal Year 2007 Results
Date:5/29/2008

HARBIN, China, May 29 /Xinhua-PRNewswire-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or "the Company"), a leading pharmaceutical company in the People's Republic of China ("PRC"), today reported solid financial results for the fourth quarter and fiscal year ended October 31, 2007.

Fourth Quarter Fiscal 2007 Highlights

-- Total revenues increased to $7.1 million, up 5% from the fourth

quarter of 2006

-- Gross profit reached $3.6 million, up 19% from the fourth quarter of

2006

-- Gross margin was 51%, up from 45% in the fourth quarter of 2006

-- Operating income totaled $1.1 million

-- Net income was $1.1 million, or $0.03 per diluted share

Full Year 2007 Highlights

-- Total revenues in 2007 were $28.0 million

-- Gross profit in 2007 was $14.3 million

-- Gross margin was 51%

-- Operating income was $9.6 million

-- Net income increased to $9.6 million, or $0.27 per fully diluted share

"This was a very key year for Renhuang Pharmaceuticals. We performed well on promotions and advertisements and enhanced our production processes. We also focused on our best selling product, Acanthopanax, and continued to work with scientific institutions to enhance our research and development capabilities," said Mr. Shaoming Li, Chairman and CEO of Renhuang. "We will continue to maintain this strategy in the year ahead and plan to explore new markets and increase sales."

Fourth Quarter 2007 Results

Renhuang's total revenues in the fourth quarter were $7.1 million, a slight increase of 5% over the fourth quarter of 2006. This was attributed to sales of its Acanthopanax products, which accounted for about 51% of the total revenues

Gross profit in the fourth quarter of 2007 was $3.6 million, an increase of 19% over the fourth quarter of 2006. Gross margin for the quarter increased to 51% from 45% in the fourth quar
'/>"/>

SOURCE Renhuang Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc.
2. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
3. Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
4. Medimetriks Pharmaceuticals, Inc. Begins Operations
5. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
6. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
7. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT
8. Jazz Pharmaceuticals, Inc. to Announce First Quarter Results on May 13, 2008
9. Aida Pharmaceuticals, Inc. Announces Update on Progress of Rh-Apo2L Testing
10. Aida Pharmaceuticals, Inc. Announces Completion of Research Institute Acquisition
11. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Cambridge Semantics ... last week’s “Data Demonstration Day” on Capitol Hill, hosted by ... EMC, Google, Microsoft and others to showcase how innovative data ... Accountability and Transparency Act (DATA Act). , Originally introduced in ... (R-CA) and Sen. Mark Warner (D-VA ), ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 The ... Annual Disruptive Innovations to Advance Clinical Trials conference taking ... Hotel in Boston, MA. , Disruptive thinkers from ... and more share bold approaches to reduce expensive infrastructure, ... “Disruptive innovation needs to be big, or novel, or ...
(Date:5/22/2013)... 2013   Oligomerix, Inc. , a privately ... therapeutics for Alzheimer,s disease (AD) and related neurodegenerative ... B financing, which includes both issuance of new ... approximately $2.8M in new investments in the Company.  ... raise. Funding from the Series ...
(Date:5/22/2013)... 2013  Empire Genomics announced today it has ... novel genomic biomarker from Cornell University for use ... help in diagnosing and determining treatment for patients ... Neuroendocrine prostate cancer (NEPC) is a lethal variant ... novo, but more commonly arises after hormonal therapy ...
Breaking Biology Technology:Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2
... Wisconsin businesses and individuals are invited ... Awards Competition, which recognizes benefits coming from research ... , ,Governor's New Products Awards are given ... more employees); large companies (500-999 employees); medium companies ...
... 2003, I wrote on an article on "The Final Death ... was on the walls of the demise of Searle due ... remaining Searle facilities in Chicago. Since then, the Searle name ... to another article I wrote on May 16, 2005, titled ...
... about $400,000 worth of software to Lad Lake ... their families. Rob Busch, enterprise sales manager for Microsoft ... non-profit's Synergy School in Milwaukee for the formal announcement. ... Lad Lakes network and software infrastructure, including the computers ...
Cached Biology Technology:Searle spirit lives on in Chicago as alumni celebrate at former home 2Searle spirit lives on in Chicago as alumni celebrate at former home 3Searle spirit lives on in Chicago as alumni celebrate at former home 4Searle spirit lives on in Chicago as alumni celebrate at former home 5
(Date:5/22/2013)... The feared Legionella pneumophila bacteria is responsible ... pneumonia. In order to infect us, this pathogen has ... and go unnoticed in our cells, thus avoiding these ... the Basque biosciences research centre, CIC bioGUNE, in which ... the USA and the National Supercomputation Centre in Barcelona ...
(Date:5/22/2013)... how climate change will affect interactions between species in ... of Animal Ecology . This knowledge, they say, is ... how species are likely to be impacted by rising ... among biologists that climate change is affecting how species ... to have very important consequences for the stability and ...
(Date:5/22/2013)... Calif., May 22, 2013 Early screening for prostate ... pregnancy testing is for women, thanks to UC Irvine ... American Chemical Society . , After more than a ... way to clearly identify clinically usable markers for prostate ... detected far sooner, with greater accuracy and at dramatically ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3
... of white blood cell types may help physicians ... and bacterial tonsillitis, potentially guiding treatment decisions, according ... Archives of Otolaryngology–Head & Neck Surgery, one of ... the tonsils) and infectious mononucleosis (caused by the ...
... has found evidence of the Earth's earliest forest trees, dating ... were uncovered after a flash flood in Gilboa, upstate New ... has known what the entire trees looked like. , ... trees which had fallen sideways, with their trunk, branches, twigs ...
... the University of Pennsylvania School of Medicine have discovered ... down a protein that is defective in cystic fibrosis ... from lung cells to airways causes thick mucus to ... therapeutic target for treating lung infections in some cystic ...
Cached Biology News:Common blood test can help distinguish between mononucleosis and tonsillitis 2Penn study on lung-infecting bacterial enzyme suggests new approach to cystic fibrosis treatment 2
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies. ...
PP2B-Abeta (C-20)...
Goat polyclonal to Duffy / FY / DARC...
... Source: Tritirachium album Description: ... endopeptidase used in a wide range of applications ... peptide bonds mainly following the carboxyl group of ... and is classified as a serine protease. ...
Biology Products: